Related references
Note: Only part of the references are listed.HLA-G 5′URR regulatory polymorphisms are associated with the risk of developing gliomas
Vladimira Durmanova et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2023)
HLA-G 14 bp In/Del and+3142 C/G genotypes are differentially expressed between patients with grade IV gliomas and controls
Kenia Cristina S. F. de Magalhaes et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Xiaoyin Bu et al.
ANNALS OF HEMATOLOGY (2021)
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy et al.
FRONTIERS IN IMMUNOLOGY (2021)
HLA-G polymorphism impacts the outcome of oral HPV infections in women
Anna Jaakola et al.
BMC INFECTIOUS DISEASES (2021)
Prediction of acute renal allograft rejection by combined HLA-G 14-bp insertion/deletion genotype analysis and detection of kidney injury molecule-1 and osteopontin in the peripheral blood
Cui-xiang Xu et al.
TRANSPLANT IMMUNOLOGY (2021)
HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer
A. D. Lazaro-Sanchez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus
Simone Negrini et al.
HUMAN IMMUNOLOGY (2020)
HLA-G: A New Immune Checkpoint in Cancer?
Danielle Krijgsman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
HLA-G Neo-Expression on Tumors
Maria Loustau et al.
FRONTIERS IN IMMUNOLOGY (2020)
Controlled hypobaric hypoxia increases immunological tolerance by modifying HLA-G expression, a potential therapy to inflammatory diseases
Marina Ziliotto et al.
MEDICAL HYPOTHESES (2020)
HLA-G Expressing Immune Cells in Immune Mediated Diseases
P. Contini et al.
FRONTIERS IN IMMUNOLOGY (2020)
The potential role of HLA-G in the pathogenesis of HBV infection: Immunosuppressive or immunoprotective?
Saadyeh Rashidi et al.
INFECTION GENETICS AND EVOLUTION (2020)
Immunoglobulin-like transcript 4 and human leukocyte antigen-G interaction promotes the progression of human colorectal cancer
Zhaoyang Cai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
HLA-G, HLA-E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma
Nadia Boujelbene et al.
HLA (2019)
CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
Clement Dumont et al.
CANCER IMMUNOLOGY RESEARCH (2019)
NK Cells as Potential Targets for Immunotherapy in Endometriosis
Aneta Sciezynska et al.
JOURNAL OF CLINICAL MEDICINE (2019)
HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival
Ashwin Ajith et al.
FASEB JOURNAL (2019)
Intercellular transfer of HLA-G: its potential in cancer immunology
Aifen Lin et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Significance of systemic immune-inflammation index in the differential diagnosis of high- and low-grade gliomas
Ruofei Liang et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Increased plasmatic soluble HLA-G levels in endometrial cancer
Hamza Ben Yahia et al.
MOLECULAR IMMUNOLOGY (2018)
Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups
Seok-Joo Chun et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Hypoxia-Driven immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational immunotherapy
Yiliang Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages
Chandra Kirana et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
HLA-G: At the Interface of Maternal-Fetal Tolerance
Leonardo M. R. Ferreira et al.
TRENDS IN IMMUNOLOGY (2017)
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
Shiv K. Gupta et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
Shiv K. Gupta et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients
Lisa Koenig et al.
HUMAN IMMUNOLOGY (2016)
Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas
Xing Fan et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients
Zhang-Yan Guo et al.
CELLULAR IMMUNOLOGY (2015)
Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study
Tao Li et al.
MOLECULAR GENETICS AND GENOMICS (2015)
Role of HLA-G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study
O. Brugiere et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
HLA-G: An Immune Checkpoint Molecule
Edgardo D. Carosella et al.
ADVANCES IN IMMUNOLOGY, VOL 127 (2015)
Association between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and cancer risk: A meta-analysis and systematic review
Yu-Zheng Ge et al.
HUMAN IMMUNOLOGY (2014)
Binding of HLA-G to ITIM-Bearing Ig-like Transcript 2 Receptor Suppresses B Cell Responses
Abderrahim Naji et al.
JOURNAL OF IMMUNOLOGY (2014)
New insights into HLA-G mediated tolerance
G. Amodio et al.
TISSUE ANTIGENS (2014)
The Dual Role of HLA-G in Cancer
Nathalie Rouas-Freiss et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
HLA-G molecules in autoimmune diseases and infections
Roberta Rizzo et al.
FRONTIERS IN IMMUNOLOGY (2014)
Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced in Vitro by Combined 5-Aza-2′-Deoxycytidine and Interferon-γ Treatments Results from a Multicentric Study
Isabela J. Wastowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Association between HLA-G 3' UTR 14-bp ins/del polymorphism and susceptibility to breast cancer
Ebrahim Eskandari-Nasab et al.
CANCER BIOMARKERS (2013)
NK cytolysis is dependent on the proportion of HLA-G expression
Bao-Guo Chen et al.
HUMAN IMMUNOLOGY (2013)
HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer
Aifen Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix
Rhea Ferguson et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Wei-Hua Yan
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Human tolerogenic DC-10: perspectives for clinical applications
Giada Amodio et al.
TRANSPLANTATION RESEARCH (2012)
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association
Eduardo A. Donadi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Association of HLA-G 3′ UTR 14-bp Insertion/Deletion Polymorphism with Hepatocellular Carcinoma Susceptibility in a Chinese Population
Yuting Jiang et al.
DNA AND CELL BIOLOGY (2011)
HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma
D. T. Lau et al.
TISSUE ANTIGENS (2011)
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway
Silvia Gregori et al.
BLOOD (2010)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
Esther M. de Kruijf et al.
JOURNAL OF IMMUNOLOGY (2010)
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Edgardo D. Carosella et al.
BLOOD (2008)
Human leukocyte antigen-G and cancer immunoediting
Mirjana Urosevic et al.
CANCER RESEARCH (2008)
CD3+CD4low and CD3+CD8low are induced by HLA-G:: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance
Abderrahirn Naji et al.
BLOOD (2007)
Soluble HLA-G molecules induce apoptosis in natural killer cells
Amy Lindaman et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2006)
Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression
TVF Hviid et al.
HUMAN IMMUNOLOGY (2006)
HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells
J LeMaoult et al.
FASEB JOURNAL (2005)
Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions:: in vivo implications in transplanted patients
S Le Rond et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells
J LeMaoult et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation
M Sasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NKCD8(+) cells and inhibit cytotoxic T cell activity through CD8 ligation
P Contini et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
The 14 bp deletion-insertion polymorphism in the 3 ' UT region of the HLA-G gene influences HLA-G mRNA stability
P Rousseau et al.
HUMAN IMMUNOLOGY (2003)
HLA-G polymorphisms in couples with recurrent spontaneous abortions
TV Hviid et al.
TISSUE ANTIGENS (2002)
Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice
A Horuzsko et al.
INTERNATIONAL IMMUNOLOGY (2001)
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
B Riteau et al.
INTERNATIONAL IMMUNOLOGY (2001)
HLA-G has a concentration-dependent effect on the generation of an allo-CTL response
K Kapasi et al.
IMMUNOLOGY (2000)
HLA-G suppresses proliferation of CD4+ T-lymphocytes
DRJ Bainbridge et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2000)
Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma
SN Wagner et al.
LANCET (2000)
Share Paper
